Dalton Pharma and Boehringer Ingelheim renew chemistry services agreement
Under the agreement Dalton will continue to provide chemistry services in support of Boehringer’s pharmaceutical development programs. Peter Pekos, president of Dalton Pharma Services, said: “We are extremely
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.